Skip to main content
. 2024 Dec 24;28(1):9. doi: 10.1007/s10456-024-09962-4

Table 3.

Adverse events—IIT population

Nintedanib
N = 30
Placebo
N = 30
p
Patients with at least one AE N (%) 26 (87%) 19 (63%) 0.072
Number of AE Events (n) 127 63
Patients with at least one AE related to treatment N (%) 25 (83%) 10 (33%) < 0.01
Number of AE related to treatment Events (n) 85 23
Patients with at least 1 serious AE N (%) 2 (7%) 4 (13%) 0.671
Number of serious AE Events (n) 3 7